AMOXICILLIN, 250mg, caps.

NST DORAAMOX2C-

Valid Article

Former Code(s): -X DORAZFR0517
Article is intended to be used with children (<12 years) ONLY.
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01CA04
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

AMOXICILLIN

Therapeutic Action

Penicillin antibacterial

Indications

Otitis media, streptococcal tonsillitis, sinusitis, bronchitis, pneumonia

Infection due to Helicobacter pylori (in combination with omeprazole and clarithromycin), leptospirosis, uncomplicated cutaneous anthrax

Typhoid fever

Completion treatment following treatment with IV penicillins or cephalosporins

Instructions for use

The 250 mg dispersible and breakable tablet is intended for paediatric use and replaces the 250 mg capsule.

The oral suspension form is reserved for neonates up to 2 months of age. To be reconstituted with filtered water.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • Oral suspension (powder or reconstituted): follow manufacturer's instructions.